Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1

Chinese Journal of Oncology

Volumn 34, Issue 8, 2012, Pages 592-595

  Zhou, Chen Fei ^a   Ji, Jun ^b   Yuan, Fei ^b   Yu, Ying Yan ^b   Liu, Bing Ya ^b   Zhang, Jun ^b   Zhu, Zheng Gang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

Gastric neoplasms; Metastasis associated 1 family member 2; Nuclear transcription factor Sp1

Indexed keywords

MESSENGER RNA; METASTASIS ASSOCIATED 1 FAMILY MEMBER 2; PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPUTER PROGRAM; CONTROLLED STUDY; DISTANT METASTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

EID: 84866491401     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.08.007     Document Type: Article

References (20)

1. Zhao P, Dai M, Chen W, et al. Cancer trends in China. Jpn J Clin Oncol, 2010, 40:281-285.
2. Lee H, Ryu SH, Hong SS, et al. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation. J Gastroenterol Hepatol, 2009, 24:1445-1450.
3. Ji Y, Zhang P, Lu Y, et al. Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication. J Huazhong Univ Sci Technolog Med Sci, 2006, 26:359-362.
4. Xia L, Zhang Y. Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene, 2001, 268:77-85.
5. Wang W, Li YF, Sun XW, et al. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer, 2010, 29:923-930.
6. Yao JC, Wang L, Wei D, et al. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res, 2004, 10:4109-4117.
7. Wilson AJ, Chueh AC, Tögel L, et al. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res, 2010, 70:609-620.
8. Toh Y, Nicolson GL. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis, 2009, 26:215-227.
9. Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem, 2003, 278:42560-42568.
10. Weichert W, Röske A, Gekeler V, et al. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol, 2008, 9:139-148.
11. Gallinari P, Di Marco S, Jones P, et al. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res, 2007, 17:195-211.
12. Luo J, Su F, Chen D, et al. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature, 2000, 408:377-381.
13. Dai C, Gu W. p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med, 2010, 16:528-536.
14. Wang L, Guan X, Zhang J, et al. Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. Int J Oncol, 2008, 33:161-167.
15. Waby JS, Chirakkal H, Yu C, et al. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol Cancer, 2010, 9:275.
16. Cucciolla V, Borriello A, Criscuolo M, et al. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis, 2008, 29:560-567.
17. Yu DC, Waby JS, Chirakkal H, et al. Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer, 2010, 9:276.